Det primære endpoint var andelen af patienter, der oplevede en klinisk effekt, bestemt som en nedgang i CDAI på ≥ 70 point fra baseline ved 4- ugers evalueringen og uden stigning i brugen af lægemidler eller kirurgiske indgreb for Crohns sygdom.
The primary endpoint was the proportion of patients who experienced a clinical response, defined as a decrease in CDAI by ≥ 70 points from baseline at the 4-week evaluation and without an increase in the use of medicinal products or surgery for Crohn’ s disease.